人工膵臓デバイスシステム市場：コンポーネント,適応症,デバイスタイプ,販売チャネル,エンドユーザー,ユーザー別-2025-2030年世界予測

人工膵臓デバイスシステム市場は、2024年には3億5,311万米ドルとなり、2025年には3億8,164万米ドル、CAGR 8.44%で成長し、2030年には5億7,435万米ドルに達すると予測されています。

人工膵臓システムは、糖尿病管理における画期的な進化を象徴しています。急速に変貌を遂げる今日のヘルスケア環境において、革新的なテクノロジーは従来の治療と最新の自動化された治療とのギャップを埋めています。ハードウェアとソフトウェアを高度に統合したこれらのシステムは、グルコースレベルを継続的にモニタリングし、それに応じて治療介入を調整することにより、正確でリアルタイムのインスリン投与を提供することを目指しています。

本エグゼクティブサマリーでは、人工膵臓を取り巻く状況を包括的に紹介し、患者ケアへの変革的な影響を強調します。センサーの精度、データ分析、アルゴリズムの最適化における技術的進歩がもたらす市場動向について考察しています。規制上の考慮事項、臨床的有効性、個別化医療の新たな役割といった重要な要素についても深く掘り下げています。意思決定者および業界専門家向け

本レポートは、技術的な深みと戦略的な洞察を融合させたバランスの取れた分析を提示しています。本レポートは、医療工学とデジタル技術の融合が、慢性疾患管理の未来をどのように再構築しつつあるのかを探るための招待状です。本論考は、人工膵臓デバイスシステムの領域に横たわる課題と機会について、読者に明確な理解を提供することを目的としています。

人工膵臓デバイスシステム市場の変革

過去数年間、人工膵臓市場は、技術的ブレークスルーと進化する患者ニーズによって、大きな変化を目の当たりにしてきました。この変化の中心は、インスリン投与の精度を劇的に高め、システムの信頼性と応答性を高める次世代センサーと制御アルゴリズムの統合です。

高度な製造技術は、デバイスの統合を洗練させ、アルゴリズム、ディスプレイ・プラットフォーム、送達メカニズムがシームレスに調和して動作することを保証する上で、重要な役割を果たしてきました。この進化は、使い勝手の向上、侵襲性の低減、患者の信頼性の向上によって裏付けられています。デジタルヘルス、データ分析、クラウド接続の融合もまた、遠隔モニタリングと糖尿病管理全体に革命をもたらしました。ヘルスケアプロバイダーは現在、リアルタイムの洞察とオーダーメイドの介入戦略から恩恵を受けています。

さらに、世界中の規制機関は、厳格な安全基準を維持しながらイノベーションを促進することの重要性を認識しています。このような規制の柔軟性により、メーカー各社は新規の医療機器をより早く市場に投入できるようになり、利用可能なソリューションの幅が広がっています。要するに、こうした変革的なシフトは、患者中心のケアと最先端テクノロジーが融合する環境を生み出し、将来の医療機器と統合ヘルスケアシステムの先例となりつつあります。

人工膵臓市場の主なセグメンテーション洞察

人工膵臓装置システムの市場を理解するには、さまざまな次元にわたる複数のセグメンテーション基準を微妙に検討する必要があります。コンポーネントの観点からは、市場は制御アルゴリズム、ディスプレイデバイス、インスリンポンプ、センサーの相互作用として調査されます。制御アルゴリズムのカテゴリーそのものは、モデル予測制御と比例積分微分制御の両方を掘り下げています。同様に、表示装置は従来のハンドヘルド装置とより現代的なウェアラブル表示装置というレンズを通して評価され、インスリンポンプはパッチ式、チューブ式、チューブレス式に分類されます。さらに、リアルタイムのモニタリングで重要な役割を果たすセンサーは、グルコースセンサーとインスリンセンサーに細分化されます。

適応症を考慮する場合、市場は対応する糖尿病のタイプ（主に1型糖尿病と2型糖尿病）によって明確に区別されます。デバイスの種類は、クローズド・ループ・システム、ハイブリッド・クローズド・ループ・システム、オープン・ループ・システムを含み、それぞれ自動化と患者関与のレベルが異なります。

分析は機器レベルだけにとどまらず、販売チャネルのセグメンテーションによって、直販、代理店、オンライン小売業者など、多様な流通メカニズムが浮き彫りになります。この構造は、診断センター、在宅医療現場、病院、医療研究機関に焦点を当てたエンドユーザーセグメンテーションによってさらに補完されます。最後に、セグメンテーション分析ではユーザーの特性を考慮し、成人（中年、高齢、若年成人にさらに分類）と小児人口を区別し、後者を青年と小児に細分化します。このような多角的なセグメンテーションアプローチにより、市場力学を詳細に把握し、製品開拓や患者ケアの動向の予測に役立てることができます。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で糖尿病の罹患率が上昇し、人工膵臓システムの必要性が高まっている
    • 低侵襲治療の需要増加
    • 糖尿病ケア機器の研究開発を支援する政府の好ましい政策と取り組み
  • 抑制要因
    • 人工膵臓デバイスシステムに関連する技術的な複雑さ
  • 機会
    • 小児専用人工膵臓システムの開発
    • AIとIoTの技術進歩を活用し、人工膵臓システムの効率を向上
  • 課題
    • 人工膵臓デバイスシステムのデータプライバシーとセキュリティに関する懸念
• 市場セグメンテーション分析
  • コンポーネント：視覚的なインターフェースで血糖値とシステム状態を監視するためのディスプレイデバイスの需要が急増
  • エンドユーザー：診断精度を高めるために、診断センターにおける人工膵臓デバイスシステムのニーズが高まっています。
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社会
  • 技術的
  • 法律上
  • 環境

第6章 人工膵臓デバイスシステム市場：コンポーネント別

• 制御アルゴリズム
  • モデル予測制御
  • 比例積分微分制御
• ディスプレイデバイス
  • 従来のハンドヘルドデバイス
  • ウェアラブルディスプレイデバイス
• インスリンポンプ
  • パッチポンプ
  • チューブポンプ
  • チューブレスポンプ
• センサー
  • グルコースセンサー
  • インスリンセンサー

第7章 人工膵臓デバイスシステム市場：適応症別

• 1型糖尿病
• 2型糖尿病

第8章 人工膵臓デバイスシステム市場：デバイスタイプ別

• 閉ループシステム
• ハイブリッド閉ループシステム
• オープンループシステム

第9章 人工膵臓デバイスシステム市場：販売チャネル別

• 直接販売
• 販売代理店
• オンライン小売業者

第10章 人工膵臓デバイスシステム市場：エンドユーザー別

• 診断センター
• 在宅ケア設定
• 病院
• 医療調査機関

第11章 人工膵臓デバイスシステム市場ユーザー別

• 大人
  • 中年成人
  • 高齢者
  • 若者
• 小児科
  • 青少年
  • 子供たち

第12章 南北アメリカの人工膵臓デバイスシステム市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第13章 アジア太平洋地域の人工膵臓デバイスシステム市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第14章 欧州・中東・アフリカの人工膵臓デバイスシステム市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第15章 競合情勢

• 市場シェア分析, 2024
• FPNVポジショニングマトリックス, 2024
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• B. Braun Melsungen AG
• Beta Bionics, Inc.
• Bigfoot Biomedical Inc.
• Dexcom, Inc.
• Diabeloop SA
• DreaMed Diabetes
• Eli Lilly and Company
• Glytec, LLC
• Inreda Diabetic B.V.
• Insulet Corporation
• Johnson & Johnson
• Medtronic PLC
• NIKKISO Co., Ltd.
• Pancreum, Inc.
• Renfrew Group International
• Securecell AG
• Senseonics Holdings, Inc.
• Sequel Med Tech, LLC
• Tandem Diabetes Care, Inc.
• The Menarini Group
• TypeZero Technologies, LLC

LIST OF FIGURES

• FIGURE 1. ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET MULTI-CURRENCY
• FIGURE 2. ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET MULTI-LANGUAGE
• FIGURE 3. ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET RESEARCH PROCESS
• FIGURE 4. ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2024 VS 2030
• FIGURE 5. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 6. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
• FIGURE 9. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
• FIGURE 11. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2024 VS 2030 (%)
• FIGURE 13. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SALES CHANNEL, 2024 VS 2030 (%)
• FIGURE 15. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SALES CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 16. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END USER, 2024 VS 2030 (%)
• FIGURE 17. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 18. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY USER, 2024 VS 2030 (%)
• FIGURE 19. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY USER, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 20. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 21. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 22. UNITED STATES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY STATE, 2024 VS 2030 (%)
• FIGURE 23. UNITED STATES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 24. ASIA-PACIFIC ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 25. ASIA-PACIFIC ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 26. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 27. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 28. ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 29. ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET DYNAMICS
• TABLE 7. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL ALGORITHMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY MODEL PREDICTIVE CONTROL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PROPORTIONAL INTEGRAL DERIVATIVE CONTROL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL ALGORITHMS, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISPLAY DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TRADITIONAL HANDHELD DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY WEARABLE DISPLAY DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISPLAY DEVICES, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PATCH PUMPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TUBED PUMPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TUBELESS PUMPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SENSORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY GLUCOSE SENSORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN SENSORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SENSORS, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CLOSED LOOP SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY HYBRID CLOSED LOOP SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY OPEN LOOP SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ONLINE RETAILERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 40. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY MEDICAL RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 41. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
• TABLE 42. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 43. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY MIDDLE-AGED ADULTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 44. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY OLDER ADULTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 45. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY YOUNG ADULTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 46. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
• TABLE 47. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 48. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADOLESCENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 49. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CHILDREN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 50. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
• TABLE 51. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 52. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL ALGORITHMS, 2018-2030 (USD MILLION)
• TABLE 53. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISPLAY DEVICES, 2018-2030 (USD MILLION)
• TABLE 54. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
• TABLE 55. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SENSORS, 2018-2030 (USD MILLION)
• TABLE 56. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 57. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 58. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 59. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 60. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
• TABLE 61. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
• TABLE 62. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
• TABLE 63. AMERICAS ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 64. ARGENTINA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 65. ARGENTINA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL ALGORITHMS, 2018-2030 (USD MILLION)
• TABLE 66. ARGENTINA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISPLAY DEVICES, 2018-2030 (USD MILLION)
• TABLE 67. ARGENTINA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
• TABLE 68. ARGENTINA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SENSORS, 2018-2030 (USD MILLION)
• TABLE 69. ARGENTINA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 70. ARGENTINA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 71. ARGENTINA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 72. ARGENTINA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 73. ARGENTINA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
• TABLE 74. ARGENTINA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
• TABLE 75. ARGENTINA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
• TABLE 76. BRAZIL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 77. BRAZIL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL ALGORITHMS, 2018-2030 (USD MILLION)
• TABLE 78. BRAZIL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISPLAY DEVICES, 2018-2030 (USD MILLION)
• TABLE 79. BRAZIL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
• TABLE 80. BRAZIL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SENSORS, 2018-2030 (USD MILLION)
• TABLE 81. BRAZIL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 82. BRAZIL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 83. BRAZIL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 84. BRAZIL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 85. BRAZIL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
• TABLE 86. BRAZIL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
• TABLE 87. BRAZIL ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
• TABLE 88. CANADA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 89. CANADA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL ALGORITHMS, 2018-2030 (USD MILLION)
• TABLE 90. CANADA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISPLAY DEVICES, 2018-2030 (USD MILLION)
• TABLE 91. CANADA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
• TABLE 92. CANADA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SENSORS, 2018-2030 (USD MILLION)
• TABLE 93. CANADA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 94. CANADA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 95. CANADA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 96. CANADA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 97. CANADA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
• TABLE 98. CANADA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
• TABLE 99. CANADA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
• TABLE 100. MEXICO ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 101. MEXICO ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL ALGORITHMS, 2018-2030 (USD MILLION)
• TABLE 102. MEXICO ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISPLAY DEVICES, 2018-2030 (USD MILLION)
• TABLE 103. MEXICO ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
• TABLE 104. MEXICO ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SENSORS, 2018-2030 (USD MILLION)
• TABLE 105. MEXICO ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 106. MEXICO ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 107. MEXICO ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 108. MEXICO ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 109. MEXICO ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
• TABLE 110. MEXICO ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
• TABLE 111. MEXICO ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
• TABLE 112. UNITED STATES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 113. UNITED STATES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL ALGORITHMS, 2018-2030 (USD MILLION)
• TABLE 114. UNITED STATES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISPLAY DEVICES, 2018-2030 (USD MILLION)
• TABLE 115. UNITED STATES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
• TABLE 116. UNITED STATES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SENSORS, 2018-2030 (USD MILLION)
• TABLE 117. UNITED STATES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 118. UNITED STATES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 119. UNITED STATES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 120. UNITED STATES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 121. UNITED STATES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
• TABLE 122. UNITED STATES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
• TABLE 123. UNITED STATES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
• TABLE 124. UNITED STATES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 125. ASIA-PACIFIC ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 126. ASIA-PACIFIC ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL ALGORITHMS, 2018-2030 (USD MILLION)
• TABLE 127. ASIA-PACIFIC ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISPLAY DEVICES, 2018-2030 (USD MILLION)
• TABLE 128. ASIA-PACIFIC ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
• TABLE 129. ASIA-PACIFIC ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SENSORS, 2018-2030 (USD MILLION)
• TABLE 130. ASIA-PACIFIC ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 131. ASIA-PACIFIC ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 132. ASIA-PACIFIC ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 133. ASIA-PACIFIC ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 134. ASIA-PACIFIC ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
• TABLE 135. ASIA-PACIFIC ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
• TABLE 136. ASIA-PACIFIC ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
• TABLE 137. ASIA-PACIFIC ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 138. AUSTRALIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 139. AUSTRALIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL ALGORITHMS, 2018-2030 (USD MILLION)
• TABLE 140. AUSTRALIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISPLAY DEVICES, 2018-2030 (USD MILLION)
• TABLE 141. AUSTRALIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
• TABLE 142. AUSTRALIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SENSORS, 2018-2030 (USD MILLION)
• TABLE 143. AUSTRALIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 144. AUSTRALIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 145. AUSTRALIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 146. AUSTRALIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 147. AUSTRALIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
• TABLE 148. AUSTRALIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
• TABLE 149. AUSTRALIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
• TABLE 150. CHINA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 151. CHINA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL ALGORITHMS, 2018-2030 (USD MILLION)
• TABLE 152. CHINA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISPLAY DEVICES, 2018-2030 (USD MILLION)
• TABLE 153. CHINA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
• TABLE 154. CHINA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SENSORS, 2018-2030 (USD MILLION)
• TABLE 155. CHINA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 156. CHINA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 157. CHINA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 158. CHINA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 159. CHINA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
• TABLE 160. CHINA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
• TABLE 161. CHINA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
• TABLE 162. INDIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 163. INDIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL ALGORITHMS, 2018-2030 (USD MILLION)
• TABLE 164. INDIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISPLAY DEVICES, 2018-2030 (USD MILLION)
• TABLE 165. INDIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
• TABLE 166. INDIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SENSORS, 2018-2030 (USD MILLION)
• TABLE 167. INDIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 168. INDIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 169. INDIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 170. INDIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 171. INDIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
• TABLE 172. INDIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
• TABLE 173. INDIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
• TABLE 174. INDONESIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 175. INDONESIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL ALGORITHMS, 2018-2030 (USD MILLION)
• TABLE 176. INDONESIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISPLAY DEVICES, 2018-2030 (USD MILLION)
• TABLE 177. INDONESIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
• TABLE 178. INDONESIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SENSORS, 2018-2030 (USD MILLION)
• TABLE 179. INDONESIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 180. INDONESIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 181. INDONESIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 182. INDONESIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 183. INDONESIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
• TABLE 184. INDONESIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
• TABLE 185. INDONESIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
• TABLE 186. JAPAN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 187. JAPAN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL ALGORITHMS, 2018-2030 (USD MILLION)
• TABLE 188. JAPAN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISPLAY DEVICES, 2018-2030 (USD MILLION)
• TABLE 189. JAPAN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
• TABLE 190. JAPAN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SENSORS, 2018-2030 (USD MILLION)
• TABLE 191. JAPAN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 192. JAPAN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 193. JAPAN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 194. JAPAN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 195. JAPAN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
• TABLE 196. JAPAN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
• TABLE 197. JAPAN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
• TABLE 198. MALAYSIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 199. MALAYSIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL ALGORITHMS, 2018-2030 (USD MILLION)
• TABLE 200. MALAYSIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISPLAY DEVICES, 2018-2030 (USD MILLION)
• TABLE 201. MALAYSIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
• TABLE 202. MALAYSIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SENSORS, 2018-2030 (USD MILLION)
• TABLE 203. MALAYSIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 204. MALAYSIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 205. MALAYSIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 206. MALAYSIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 207. MALAYSIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
• TABLE 208. MALAYSIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
• TABLE 209. MALAYSIA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
• TABLE 210. PHILIPPINES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 211. PHILIPPINES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL ALGORITHMS, 2018-2030 (USD MILLION)
• TABLE 212. PHILIPPINES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISPLAY DEVICES, 2018-2030 (USD MILLION)
• TABLE 213. PHILIPPINES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
• TABLE 214. PHILIPPINES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SENSORS, 2018-2030 (USD MILLION)
• TABLE 215. PHILIPPINES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 216. PHILIPPINES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 217. PHILIPPINES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 218. PHILIPPINES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 219. PHILIPPINES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
• TABLE 220. PHILIPPINES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
• TABLE 221. PHILIPPINES ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
• TABLE 222. SINGAPORE ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 223. SINGAPORE ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL ALGORITHMS, 2018-2030 (USD MILLION)
• TABLE 224. SINGAPORE ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISPLAY DEVICES, 2018-2030 (USD MILLION)
• TABLE 225. SINGAPORE ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
• TABLE 226. SINGAPORE ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SENSORS, 2018-2030 (USD MILLION)
• TABLE 227. SINGAPORE ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 228. SINGAPORE ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 229. SINGAPORE ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 230. SINGAPORE ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 231. SINGAPORE ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
• TABLE 232. SINGAPORE ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
• TABLE 233. SINGAPORE ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
• TABLE 234. SOUTH KOREA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 235. SOUTH KOREA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL ALGORITHMS, 2018-2030 (USD MILLION)
• TABLE 236. SOUTH KOREA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISPLAY DEVICES, 2018-2030 (USD MILLION)
• TABLE 237. SOUTH KOREA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
• TABLE 238. SOUTH KOREA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SENSORS, 2018-2030 (USD MILLION)
• TABLE 239. SOUTH KOREA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 240. SOUTH KOREA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 241. SOUTH KOREA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 242. SOUTH KOREA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 243. SOUTH KOREA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
• TABLE 244. SOUTH KOREA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
• TABLE 245. SOUTH KOREA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
• TABLE 246. TAIWAN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 247. TAIWAN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL ALGORITHMS, 2018-2030 (USD MILLION)
• TABLE 248. TAIWAN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISPLAY DEVICES, 2018-2030 (USD MILLION)
• TABLE 249. TAIWAN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
• TABLE 250. TAIWAN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SENSORS, 2018-2030 (USD MILLION)
• TABLE 251. TAIWAN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 252. TAIWAN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 253. TAIWAN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 254. TAIWAN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 255. TAIWAN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
• TABLE 256. TAIWAN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
• TABLE 257. TAIWAN ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
• TABLE 258. THAILAND ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 259. THAILAND ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL ALGORITHMS, 2018-2030 (USD MILLION)
• TABLE 260. THAILAND ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISPLAY DEVICES, 2018-2030 (USD MILLION)
• TABLE 261. THAILAND ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
• TABLE 262. THAILAND ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SENSORS, 2018-2030 (USD MILLION)
• TABLE 263. THAILAND ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 264. THAILAND ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 265. THAILAND ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 266. THAILAND ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 267. THAILAND ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
• TABLE 268. THAILAND ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
• TABLE 269. THAILAND ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
• TABLE 270. VIETNAM ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 271. VIETNAM ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL ALGORITHMS, 2018-2030 (USD MILLION)
• TABLE 272. VIETNAM ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISPLAY DEVICES, 2018-2030 (USD MILLION)
• TABLE 273. VIETNAM ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
• TABLE 274. VIETNAM ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SENSORS, 2018-2030 (USD MILLION)
• TABLE 275. VIETNAM ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 276. VIETNAM ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 277. VIETNAM ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 278. VIETNAM ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 279. VIETNAM ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
• TABLE 280. VIETNAM ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
• TABLE 281. VIETNAM ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
• TABLE 282. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 283. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL ALGORITHMS, 2018-2030 (USD MILLION)
• TABLE 284. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISPLAY DEVICES, 2018-2030 (USD MILLION)
• TABLE 285. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
• TABLE 286. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SENSORS, 2018-2030 (USD MILLION)
• TABLE 287. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 288. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 289. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 290. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 291. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY USER, 2018-2030 (USD MILLION)
• TABLE 292. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
• TABLE 293. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY PEDIATRICS, 2018-2030 (USD MILLION)
• TABLE 294. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 295. DENMARK ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 296. DENMARK ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY CONTROL ALGORITHMS, 2018-2030 (USD MILLION)
• TABLE 297. DENMARK ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DISPLAY DEVICES, 2018-2030 (USD MILLION)
• TABLE 298. DENMARK ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INSULIN PUMPS, 2018-2030 (USD MILLION)
• TABLE 299. DENMARK ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SENSORS, 2018-2030 (USD MILLION)
• TABLE 300. DENMARK ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 301. DENMARK ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 302. DENMARK ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
• TABLE 303. DENMARK ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 304. DENMARK ARTIFICIAL PANCREAS DEVICE SYSTEM MARKET SIZE, BY USER, 2018-2030 (USD MI

The Artificial Pancreas Device System Market was valued at USD 353.11 million in 2024 and is projected to grow to USD 381.64 million in 2025, with a CAGR of 8.44%, reaching USD 574.35 million by 2030.

The artificial pancreas device system represents a groundbreaking evolution in diabetes management. In today's rapidly transforming healthcare environment, innovative technologies have bridged the gap between traditional treatments and modern, automated care. As a sophisticated integration of hardware and software, these systems aim to provide precise, real-time insulin delivery by continuously monitoring glucose levels and adjusting therapeutic interventions accordingly.

This executive summary introduces a comprehensive exploration of the artificial pancreas landscape, emphasizing its transformative impact on patient care. It reflects on market trends driven by technological advances in sensor accuracy, data analytics, and algorithm optimization. The content takes a deep dive into key factors such as regulatory considerations, clinical effectiveness, and the emergent role of personalized medicine. For decision-makers and industry experts,

this report presents a balanced analysis that marries technical depth with strategic insights. It is an invitation to explore how the convergence of medical engineering and digital innovation is reshaping the future of chronic disease management. This discussion is designed to offer readers a clear understanding of the challenges and opportunities that lie ahead in the realm of artificial pancreas device systems.

Transformative Shifts in the Artificial Pancreas Landscape

Over the past few years, the artificial pancreas market has witnessed substantial transformation driven by technological breakthroughs and evolving patient needs. Central to this change is the integration of next-generation sensors and control algorithms that dramatically enhance the precision of insulin delivery, making systems both more reliable and responsive.

Advanced manufacturing has played a critical role in refining device integration, thereby ensuring that algorithms, display platforms, and delivery mechanisms operate in seamless harmony. This evolution is underscored by improved usability, reduced invasiveness, and heightened patient confidence. The convergence of digital health, data analytics, and cloud connectivity has also revolutionized remote monitoring and the overall management of diabetes. Healthcare providers now benefit from real-time insights and tailored intervention strategies.

Furthermore, regulatory bodies around the world have recognized the importance of facilitating innovation while maintaining rigorous safety standards. Such regulatory flexibility has enabled manufacturers to bring novel device iterations to market faster, thus amplifying the spectrum of available solutions. In essence, these transformative shifts are creating an environment where patient-centric care meets state-of-the-art technology, setting a precedent for future medical devices and integrated healthcare systems.

Key Segmentation Insights in Artificial Pancreas Markets

Understanding the market for artificial pancreas device systems involves a nuanced examination of multiple segmentation criteria across various dimensions. From the component perspective, the market is studied as an interplay between control algorithms, display devices, insulin pumps, and sensors. The control algorithms category itself delves into the specifics of both model predictive control and proportional integral derivative control. Similarly, display devices are evaluated through the lenses of traditional handheld devices and the more contemporary wearable display devices, while insulin pumps are categorized into patch, tubed, and tubeless systems. Moreover, sensors, which play a pivotal role in real-time monitoring, are subdivided into glucose sensors and insulin sensors.

When considering the indication, the market is clearly differentiated by the type of diabetes addressed - primarily, Type 1 and Type 2 diabetes - each with its distinct clinical and therapeutic profiles. Device type segmentation further refines this analysis, encompassing closed loop systems, hybrid closed loop systems, and open loop systems, each representing varying levels of automation and patient engagement.

Analysis does not stop at the device level; the sales channel segmentation brings to light the diverse distribution mechanisms including direct sales, distributors, and online retailers. This structure is further complemented by the end user segmentation, which focuses on diagnostic centers, homecare settings, hospitals, and medical research institutes. Finally, the segmentation analysis takes into account the characteristics of the user, distinguishing between adults - who are further classified into middle-aged, older, and young adults - and the pediatric population, subdividing the latter into adolescents and children. This multifaceted segmentation approach provides a granular view of market dynamics and helps predict evolving trends in product development and patient care.

Based on Component, market is studied across Control Algorithms, Display Devices, Insulin Pumps, and Sensors. The Control Algorithms is further studied across Model Predictive Control and Proportional Integral Derivative Control. The Display Devices is further studied across Traditional Handheld Devices and Wearable Display Devices. The Insulin Pumps is further studied across Patch Pumps, Tubed Pumps, and Tubeless Pumps. The Sensors is further studied across Glucose Sensors and Insulin Sensors.

Based on Indication, market is studied across Type 1 Diabetes and Type 2 Diabetes.

Based on Device Type, market is studied across Closed Loop Systems, Hybrid Closed Loop Systems, and Open Loop Systems.

Based on Sales Channel, market is studied across Direct Sales, Distributors, and Online Retailers.

Based on End User, market is studied across Diagnostic Centers, Homecare Settings, Hospitals, and Medical Research Institutes.

Based on User, market is studied across Adults and Pediatrics. The Adults is further studied across Middle-Aged Adults, Older Adults, and Young Adults. The Pediatrics is further studied across Adolescents and Children.

Key Regional Insights Across Global Markets

The global market for artificial pancreas device systems exhibits significant regional variation that reflects different healthcare priorities, regulatory environments, and economic conditions. In the Americas, there has been a pronounced adoption of innovative technology, driven by a robust healthcare infrastructure and high patient expectations. This region has not only pioneered early clinical trials but also continues to implement advanced integrated systems in routine healthcare practices.

In Europe, Middle East & Africa, a growing emphasis on quality of life and patient-centric care has spurred investments in research and development. Countries in this region are increasingly aligning with regulatory frameworks that support medical innovation, thereby fostering an environment ripe for the introduction of cutting-edge technologies. Meanwhile, the Asia-Pacific region has emerged as a dynamic arena characterized by rapid technological adoption and significant market growth. Investment in large-scale pilot studies and governmental support for chronic disease management programs are noteworthy drivers that indicate a promising future for artificial pancreas systems in these markets.

These regional insights underscore the diverse approaches taken around the world to manage diabetes, with each region contributing unique perspectives and opportunities that collectively propel global advancements in healthcare technology.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Leading Innovations in Artificial Pancreas Systems

The competitive landscape in the artificial pancreas market is shaped by a diverse array of pioneering companies that are redefining standards in diabetes management. Industry leaders such as Abbott Laboratories, B. Braun Melsungen AG, Beta Bionics, Inc., and Bigfoot Biomedical Inc. are at the forefront of developing next-generation devices that integrate advanced technologies and innovative design solutions. Other influential players like Dexcom, Inc., Diabeloop SA, and DreaMed Diabetes push the envelope further by leveraging integrated data analytics to enhance device responsiveness and patient outcomes.

In addition, companies such as Eli Lilly and Company, Glytec, LLC, Inreda Diabetic B.V., and Insulet Corporation have demonstrated a commitment to both clinical efficacy and user-friendly design in their product innovations. Furthermore, industry giants like Johnson & Johnson and Medtronic PLC continue to invest heavily in technology that complements their extensive healthcare portfolios, while newer entrants including NIKKISO Co., Ltd., Pancreum, Inc., Renfrew Group International, and Securecell AG are steadily gaining ground with their disruptive approaches. The landscape is rounded out by notable innovators such as Senseonics Holdings, Inc., Sequel Med Tech, LLC, Tandem Diabetes Care, Inc., The Menarini Group, and TypeZero Technologies, LLC - each contributing uniquely to a market that is evolving at an unprecedented pace.

Collectively, these companies are not only catalysts for technological innovation but also serve as reference points for regulatory, clinical, and market-driven benchmarks. Their influential presence reinforces the role of strategic partnerships and continuous improvement in driving the overall momentum of the artificial pancreas systems market.

The report delves into recent significant developments in the Artificial Pancreas Device System Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, B. Braun Melsungen AG, Beta Bionics, Inc., Bigfoot Biomedical Inc., Dexcom, Inc., Diabeloop SA, DreaMed Diabetes, Eli Lilly and Company, Glytec, LLC, Inreda Diabetic B.V., Insulet Corporation, Johnson & Johnson, Medtronic PLC, NIKKISO Co., Ltd., Pancreum, Inc., Renfrew Group International, Securecell AG, Senseonics Holdings, Inc., Sequel Med Tech, LLC, Tandem Diabetes Care, Inc., The Menarini Group, and TypeZero Technologies, LLC. Actionable Recommendations for Industry Leaders

Industry leaders aiming to secure a competitive edge in the artificial pancreas systems market must adopt a proactive, multi-pronged strategy that balances innovation with practicality. It is essential to invest in research and development initiatives that focus on enhancing algorithm precision, sensor accuracy, and overall system reliability. Continuous improvement in device interoperability and data integration will help bridge operational gaps between hardware components and cloud-based analytics platforms.

Leaders should prioritize partner collaborations with hospitals, clinical research centers, and technology innovators to foster an ecosystem that supports seamless device integration and rapid market responsiveness. Another strategic recommendation is to invest in user-centric design principles that not only meet the needs of a diverse patient base but also ensure compliance with the latest regulatory standards. By tailoring solutions to address both adult and pediatric requirements, companies can capture a broader market share and improve patient adherence.

Furthermore, it is crucial for companies to expand their geographical footprint by entering emerging markets where the need for advanced healthcare solutions is rising. Expanding direct sales channels and optimizing distribution networks in regions such as Asia-Pacific and Europe, Middle East & Africa can lead to greater market penetration. Finally, industry players should leverage insights from rigorous real-world data studies to inform product updates and future innovations. This data-driven approach, combined with agile market strategies, will drive sustainable growth and ensure long-term success in an increasingly competitive landscape.

Conclusion and Future Outlook

In wrapping up this analysis, it is clear that the artificial pancreas device system market stands at the nexus of technological innovation and transformative healthcare delivery. The detailed segmentation, regional dynamics, and leading company insights paint a promising picture of an industry that is poised for rapid evolution. With an array of technological advancements, from refined control algorithms to next-generation sensor technology, the future of diabetes management is transitioning towards more automated, adaptive, and patient-responsive systems.

This comprehensive review underscores the importance of staying abreast of emerging trends and fostering innovations that prioritize patient safety and treatment efficacy. As the market shifts, both incumbents and new entrants have opportunities to redefine standards in medical care through strategic investments, collaborative ventures, and relentless innovation. The journey towards fully automated diabetes management is well underway, and the potential benefits for patient outcomes are immense.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing prevalence of diabetes worldwide increasing the need for artificial pancreas systems
    • 5.1.1.2. Increasing demand for minimally invasive treatments
    • 5.1.1.3. Favorable government policies and initiatives supporting research and development of diabetes care devices
  • 5.1.2. Restraints
    • 5.1.2.1. Technological complexities associated with artificial pancreas device system
  • 5.1.3. Opportunities
    • 5.1.3.1. Development of pediatric-specific artificial pancreas systems
    • 5.1.3.2. Leveraging technological advancements in AI and IoT to improve artificial pancreas system efficiency
  • 5.1.4. Challenges
    • 5.1.4.1. Concerns associated with data privacy and security of artificial pancreas device system
• 5.2. Market Segmentation Analysis
  • 5.2.1. Component: Proliferating need for display devices to monitor glucose levels and system status with a visual interface
  • 5.2.2. End User: Increasing need for artificial pancreas device systems among diagnostic centers to enhance diagnostic accuracy
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Artificial Pancreas Device System Market, by Component

• 6.1. Introduction
• 6.2. Control Algorithms
  • 6.2.1. Model Predictive Control
  • 6.2.2. Proportional Integral Derivative Control
• 6.3. Display Devices
  • 6.3.1. Traditional Handheld Devices
  • 6.3.2. Wearable Display Devices
• 6.4. Insulin Pumps
  • 6.4.1. Patch Pumps
  • 6.4.2. Tubed Pumps
  • 6.4.3. Tubeless Pumps
• 6.5. Sensors
  • 6.5.1. Glucose Sensors
  • 6.5.2. Insulin Sensors

7. Artificial Pancreas Device System Market, by Indication

• 7.1. Introduction
• 7.2. Type 1 Diabetes
• 7.3. Type 2 Diabetes

8. Artificial Pancreas Device System Market, by Device Type

• 8.1. Introduction
• 8.2. Closed Loop Systems
• 8.3. Hybrid Closed Loop Systems
• 8.4. Open Loop Systems

9. Artificial Pancreas Device System Market, by Sales Channel

• 9.1. Introduction
• 9.2. Direct Sales
• 9.3. Distributors
• 9.4. Online Retailers

10. Artificial Pancreas Device System Market, by End User

• 10.1. Introduction
• 10.2. Diagnostic Centers
• 10.3. Homecare Settings
• 10.4. Hospitals
• 10.5. Medical Research Institutes

11. Artificial Pancreas Device System Market, by User

• 11.1. Introduction
• 11.2. Adults
  • 11.2.1. Middle-Aged Adults
  • 11.2.2. Older Adults
  • 11.2.3. Young Adults
• 11.3. Pediatrics
  • 11.3.1. Adolescents
  • 11.3.2. Children

12. Americas Artificial Pancreas Device System Market

• 12.1. Introduction
• 12.2. Argentina
• 12.3. Brazil
• 12.4. Canada
• 12.5. Mexico
• 12.6. United States

13. Asia-Pacific Artificial Pancreas Device System Market

• 13.1. Introduction
• 13.2. Australia
• 13.3. China
• 13.4. India
• 13.5. Indonesia
• 13.6. Japan
• 13.7. Malaysia
• 13.8. Philippines
• 13.9. Singapore
• 13.10. South Korea
• 13.11. Taiwan
• 13.12. Thailand
• 13.13. Vietnam

14. Europe, Middle East & Africa Artificial Pancreas Device System Market

• 14.1. Introduction
• 14.2. Denmark
• 14.3. Egypt
• 14.4. Finland
• 14.5. France
• 14.6. Germany
• 14.7. Israel
• 14.8. Italy
• 14.9. Netherlands
• 14.10. Nigeria
• 14.11. Norway
• 14.12. Poland
• 14.13. Qatar
• 14.14. Russia
• 14.15. Saudi Arabia
• 14.16. South Africa
• 14.17. Spain
• 14.18. Sweden
• 14.19. Switzerland
• 14.20. Turkey
• 14.21. United Arab Emirates
• 14.22. United Kingdom

15. Competitive Landscape

• 15.1. Market Share Analysis, 2024
• 15.2. FPNV Positioning Matrix, 2024
• 15.3. Competitive Scenario Analysis
  • 15.3.1. Integration of Abbott's FreeStyle Libre 3 Plus enhances the iLet Bionic Pancreas system with real-time glucose monitoring and streamlined insulin delivery
  • 15.3.2. Insulet's Omnipod 5 enhances diabetes care with FDA approval for Type 2 insulin delivery system
  • 15.3.3. FDA clearance of twiist automated insulin system enhances precision and accessibility for type 1 diabetes patients
  • 15.3.4. Insulet announces CE Mark approval of Omnipod 5 integration with Abbott FreeStyle Libre 2 Plus sensor
  • 15.3.5. Beta Bionics unveils nationwide launch of iLet Bionic Pancreas integrated with Dexcom G7 CGM device
• 15.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. B. Braun Melsungen AG
• 3. Beta Bionics, Inc.
• 4. Bigfoot Biomedical Inc.
• 5. Dexcom, Inc.
• 6. Diabeloop SA
• 7. DreaMed Diabetes
• 8. Eli Lilly and Company
• 9. Glytec, LLC
• 10. Inreda Diabetic B.V.
• 11. Insulet Corporation
• 12. Johnson & Johnson
• 13. Medtronic PLC
• 14. NIKKISO Co., Ltd.
• 15. Pancreum, Inc.
• 16. Renfrew Group International
• 17. Securecell AG
• 18. Senseonics Holdings, Inc.
• 19. Sequel Med Tech, LLC
• 20. Tandem Diabetes Care, Inc.
• 21. The Menarini Group
• 22. TypeZero Technologies, LLC